Home
Neuroscientific Biopharmaceuticals Ltd
ASX Code
NSB
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
https://neuroscientific.com/investors/#asx-announcements
Website
https://neuroscientific.com/
About
Biopharmaceutical innovation and world class R&D NSB (ASX:NSB) is a drug development company focused on developing peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need. The NSB product portfolio includes several therapeutic peptides that are modeled on the domains of a naturally occurring protein called Metallothionein-II (MT-II). EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II.
News
NeuroScientific Biopharmaceuticals (ASX: NSB) – Webinar Presentation |
Peptide based therapies for neurodegenerative conditions |